Paclitaxel
Last Updated: 09/19/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48852 publications
Corrigendum to "Naturally derived Erythrinin C targets γ-secretase signaling to suppress triple-negative breast cancer progression and reverse paclitaxel resistance" [Phytomedicine 154 (2026) 158016].
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: September 07, 2026
Reduction-responsive cationic bolaamphiphile vesicles as a versatile platform for photodynamic and chemotherapeutic delivery.
Journal: Journal of liposome research
Published: September 02, 2026
Evaluation of Drug Cost-Saving Effects of Drug Vial Optimization Using an Anticancer Drug Compounding Robot: A Single-center Study
Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Published: September 02, 2026
Use of sacituzumab govitecan in HR+/HER2- metastatic breast cancer following progression on endocrine therapy and chemotherapy: a case report in line with the results of the TROPiCS-02 study.
Journal: Recenti progressi in medicina
Published: September 02, 2026
Engineered matrices reveal sulfation-mediated stress adaptation and drug-specific modulation of chemotherapeutic response.
Journal: Biomaterials science
Published: September 01, 2026
Lysophospholipid-TRPV1 interactions in chemotherapy-induced neuropathy.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 26, 2026
Impact of Adjusted Creatinine Clearance on Carboplatin Dosing in Endometrial Cancer: A Retrospective Study.
Journal: Biological & pharmaceutical bulletin
Published: August 26, 2026
Induction Paclitaxel-Cisplatin-Capecitabine for Nasopharyngeal Carcinoma.
Journal: NEJM evidence
Published: August 25, 2026
HER2-positive salivary duct carcinoma: durable response to targeted therapy and chemotherapy.
Journal: BMJ case reports
Published: August 24, 2026
A Review on Analytical Insights into Impurity Profiling of Selected Anticancer Agents: Tinibs and Taxanes.
Journal: Critical reviews in analytical chemistry
Published: August 23, 2026
Human Wings Apart-Like Protein as a Serum Diagnostic Biomarker in Cervical Cancer: An Integrative Bioinformatics Analysis with Serum Validation.
Journal: Journal of visualized experiments : JoVE
Published: August 22, 2026
Pathologic Complete Response (pCR) Rate and Predictors of Response to Taxane, Trastuzumab, and Pertuzumab in HER2‑Positive Breast Cancer: Secondary Analyses of EA1181/CompassHER2 pCR.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 20, 2026
Last Updated: 09/19/2026